KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $15.59 Friday, 26th Apr 2024 URGN stock ended at $14.15. This is 2.39% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Jun 20, 2017 $16.01 $16.01 $15.25 $15.89 34 013
Jun 19, 2017 $15.80 $15.90 $15.37 $15.63 27 843
Jun 16, 2017 $15.38 $15.84 $14.61 $15.61 68 131
Jun 15, 2017 $15.60 $16.53 $14.87 $15.13 28 211
Jun 14, 2017 $16.11 $16.25 $14.52 $15.72 91 440
Jun 13, 2017 $16.20 $16.50 $15.57 $16.21 50 430
Jun 12, 2017 $16.35 $16.68 $15.75 $16.36 18 185
Jun 09, 2017 $17.78 $17.99 $16.13 $16.40 20 767
Jun 08, 2017 $18.18 $18.22 $17.50 $17.51 10 273
Jun 07, 2017 $17.50 $18.00 $17.50 $17.89 35 563
Jun 06, 2017 $17.86 $18.25 $17.85 $17.85 10 789
Jun 05, 2017 $18.51 $18.65 $18.20 $18.50 8 766
Jun 02, 2017 $18.93 $19.38 $18.35 $18.64 35 158
Jun 01, 2017 $17.90 $18.60 $17.20 $18.60 109 014
May 31, 2017 $19.80 $19.80 $17.39 $17.85 54 857
May 30, 2017 $18.75 $19.67 $18.50 $18.93 86 400
May 26, 2017 $18.41 $18.48 $17.88 $18.48 41 132
May 25, 2017 $18.80 $18.80 $18.02 $18.41 13 910
May 24, 2017 $19.00 $19.00 $18.03 $18.70 9 275
May 23, 2017 $19.87 $19.87 $18.50 $18.55 13 034
May 22, 2017 $19.19 $20.02 $18.01 $18.90 44 473
May 19, 2017 $17.90 $19.26 $17.73 $18.85 59 018
May 18, 2017 $16.89 $18.00 $16.50 $18.00 46 550
May 17, 2017 $16.92 $17.22 $16.38 $16.43 17 366
May 16, 2017 $17.25 $17.25 $16.35 $17.13 98 276
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT